MILWAUKIE, Ore., Oct. 11, 2019 /PRNewswire/ -- Monterey Health Center today announced a recent event that may have impacted the privacy of personal information relating to certain current and former patients. While Monterey Health Center is unaware of any attempted or actual misuse of personal information in relation to the event, they are providing potentially affected

PALO ALTO, Calif., Oct. 11, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced promising safety, efficacy and durability data from its ongoing Phase 1b study of its investigational therapy KS

DUBLIN, Oct. 11, 2019 /PRNewswire/ -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical company with a more than 70-year heritage in ophthalmology and Molecular Partners (SIX: MOLN), a clinical-stage biopharmaceutical company developing a new class of drugs known as DARPin® therapies, today announced two-year data from the CEDAR and SEQUOIA clinical studies

ROCKVILLE, Md., Oct. 11, 2019 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced interim data from the ongoing Phase I/IIa trial of RGX-314 for the treatment of wet age-re

FRESNO, Calif., Oct. 11, 2019 /PRNewswire/ -- Central Valley Regional Center ("CVRC") has become aware of a data security incident that may have involved the personal and protected health information of some of the individuals it serves. CVRC is sending notification letters to the potentially impacted individuals to notify them of this incident and to provide resources t

CLEARWATER, Fla., Oct. 11, 2019 /PRNewswire/ -- WestCMR, the world's leading healthcare industry surplus surgical supply company, is proud to celebrate supply chain professionals, during National Health Care Supply Chain Week (SC Week) October 6-12, for the important role they play in today's rapidly changing sustainable h

DAVENPORT, Fla., Oct. 11, 2019 /PRNewswire/ -- Marizyme, Inc. ("Marizyme" or the "Company"), a publicly traded (OTC:MRZM) company focused on acquiring late-stage drug assets to develop for use in the acute care space, announced today that they have agreed to exclusively distribute Somahlution's DuraGraft® products in Mexico

LOS ANGELES, Oct. 11, 2019 /PRNewswire/ -- Turn Therapeutics™, Inc., a Los Angeles-based pharmaceutical and medical device company, has announced FDA clearance of Protego™ Antimicrobial Wound Dressing, an important and disruptive innovation to traditional petroleum saturated gauze dressings. Protego™ wound dressings are

INDIANAPOLIS, Oct. 11, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved REYVOW™ (lasmiditan) an oral medication for the acute treatment of migraine, with or without aura, in adults. REYVOW has a unique mechanism of action and is the first and only FDA-approved medicine in a new clas

MINNEAPOLIS, Oct. 11, 2019 /PRNewswire/ -- Minneapolis-based health insurance marketplace and benefits partner, Gravie, is announcing an individual coverage health reimburse